Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
The historical rank and industry rank for Novateor Research Laboratories's Net Current Asset Value or its related term are showing as below:
BOM:542771'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.59 Med: 1.65 Max: 3.9
Current: 2.43
During the past 10 years, the highest Price-to-Net-Current-Asset-Value Ratio of Novateor Research Laboratories was 3.90. The lowest was 0.59. And the median was 1.65.
BOM:542771's Price-to-Net-Current-Asset-Value is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 4.195
vs BOM:542771: 2.43
Novateor Research Laboratories (BOM:542771) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Novateor Research Laboratories Net Current Asset Value Related Terms
Novateor Research Laboratories Net Current Asset Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novateor Research Laboratories Net Current Asset Value Chart
BOM:542771 vs PG, CL, KVUE: Net Current Asset Value Comparison
For the Household & Personal Products subindustry, Novateor Research Laboratories's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novateor Research Laboratories Price-to-Net-Current-Asset-Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Novateor Research Laboratories's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Novateor Research Laboratories's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of ₹13.54 mean?
Novateor Research Laboratories (BOM:542771) has a Net Current Asset Value of ₹13.54 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Novateor Research Laboratories and its competitors. This is 721% above median its historical median of 1.65. Over the past decade, Novateor Research Laboratories' Net Current Asset Value has ranged from 0.59 to 3.90.
Is Novateor Research Laboratories' Net Current Asset Value too high?
Novateor Research Laboratories' current Net Current Asset Value of ₹13.54 is 721% above median its 10-year median of 1.65. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 3.90. Overall, Novateor Research Laboratories has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Novateor Research Laboratories' Net Current Asset Value compare to PG and CL?
Novateor Research Laboratories' Net Current Asset Value of ₹13.54 can be compared against companies in the Consumer Packaged Goods industry. The industry median Net Current Asset Value is 4.20. Historically, Novateor Research Laboratories' own Net Current Asset Value has ranged from 0.59 to 3.90 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Consumer Packaged Goods company?
The median Net Current Asset Value among Consumer Packaged Goods companies is 4.20, based on 1,052 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Novateor Research Laboratories and its competitors. For the Consumer Packaged Goods industry, the median Net Current Asset Value is 4.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novateor Research Laboratories's current Net Current Asset Value is ₹13.54, which is 721% above median its own 10-year median of 1.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novateor Research Laboratories stock overvalued right now?
Novateor Research Laboratories (BOM:542771) has a current Net Current Asset Value of ₹13.54. The stock's GF Value™ is ₹83.64, compared to a current price of ₹32.85 — trading 60.7% below its estimated fair value. The current Net Current Asset Value is ₹13.54, which is 721% above median its 10-year median of 1.65. Novateor Research Laboratories' overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Novateor Research Laboratories (BOM:542771), the current Net Current Asset Value is ₹13.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novateor Research Laboratories (BOM:542771) Overvalued in 2026?
Based on GuruFocus' analysis, Novateor Research Laboratories stock appears to be undervalued.
The current stock price of ₹32.85 is trading 60.7% below its estimated GF Value™ of ₹83.64.
Key valuation signals for BOM:542771:
Net Current Asset Value: ₹13.54 (721% above median its 10-year median of 1.65)
GF Value™: ₹83.64 vs. price of ₹32.85 (60.7% below fair value)
No single metric tells the full story. See the BOM:542771 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novateor Research Laboratories Ltd is a company engaged in the development of novel personal care products that are intended to provide safe, easy, and innovative approaches to the existing traditional personal care solutions. The company's teeth-whitening products are sold under the brand name SmiloShine. The company manufactures three different variants of teeth whitening strips, teeth whitening toothpaste and brush, kids's toothpaste and tongue cleaner, and teeth whitening gel.
59GF Score
Get the complete analysis for BOM:542771
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542771 has been successfully added to your 
